NEW YORK (360Dx) – Quest Diagnostics announced today that it has partnered with Thermo Fisher Scientific to offer the company's next-generation sequencing-based companion diagnostic panel for non-small cell lung cancer.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.